Comment on “Therapeutic Effects and Biomarkers in Sublingual Immunotherapy : A Review”

Numerous sublingual immunotherapy studies have shown efficacy using a wide variety of dosing regimens. Despite a few grade III and one anaphylactic reaction due to a patient over-dose, there have been no fatal reactions resulting from sublingual immunotherapy treatment. Although safer than SCIT, SLI...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy 2012-01, Vol.2012 (2012), p.1-2
Main Authors: Kroker, George F., Sabnis, Vijay K., Morris, Mary S., Thompson, James C.
Format: Article
Language:English
Subjects:
Letter to the Editor
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Numerous sublingual immunotherapy studies have shown efficacy using a wide variety of dosing regimens. Despite a few grade III and one anaphylactic reaction due to a patient over-dose, there have been no fatal reactions resulting from sublingual immunotherapy treatment. Although safer than SCIT, SLIT is still immunotherapy. Special consideration should be given to what will ensure the highest level of safety for the patient given his or her history, exam and allergy test results. Dosing levels for sublingual immunotherapy should be based on what is therapeutically effective for each individual patient and adjusted accordingly throughout the treatment course.
ISSN:1687-9783
1687-9791
DOI:10.1155/2012/969861